# Vas Narasimhan

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/vas-narasimhan
Canonical HTML page: https://getbiobrief.com/entity/vas-narasimhan

## Timeline

- **2026-02-21**: Market Assessment — Analysts begin evaluating the long-term impact on Novartis's margins and the broader pharma supply chain.
- **2026-02-20**: Expansion Announcement — President Trump publicly states that Novartis will expand its U.S. manufacturing footprint due to tariffs.
- **2026-02-18**: White House Meeting — CEO Vas Narasimhan meets with President Trump to discuss the pharmaceutical industry and trade.

## Recent coverage (1 stories)

### Trump Credits Tariffs for Novartis Manufacturing Expansion in US
2026-02-20 11:59:37 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

President Donald Trump announced that Novartis AG will expand its U.S. manufacturing footprint following a White House meeting with CEO Vas Narasimhan. The administration attributes this shift to the impact of trade tariffs, signaling a potential trend of onshoring for major pharmaceutical players.
Full story: https://getbiobrief.com/story/trump-tariffs-novartis-us-expansion

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.